Point72 Asset Management
SLDB icon

Point72 Asset Management’s Solid Biosciences SLDB Stock Holding History

Point72 Asset Management’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.8M Sell
2,050,843
-365,265
-15% -$2.35M 0.02% 989
2025
Q4 		$13.6M Buy
2,416,108
+1,083,103
+81% +$5.87M 0.02% 1152
2025
Q3 		$8.22M Buy
1,333,005
+66,948
+5% +$391K 0.01% 879
2025
Q2 		$6.17M Buy
1,266,057
+1,064,638
+529% +$3.76M 0.01% 899
2025
Q1 		$745K Buy
+201,419
New +$862K ﹤0.01% 1526
2024
Q4 		– Sell
-443,010
Closed -$3.09M – 2421
2024
Q3 		$3.09M Buy
443,010
+330,234
+293% +$2.68M 0.01% 1031
2024
Q2 		$639K Buy
+112,776
New +$1.01M ﹤0.01% 1381

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Point72 Asset Management's SLDB Position: Q1 2026 in Review

Point72 Asset Management reduced its Solid Biosciences (SLDB) stake by 15% in Q1 2026, selling an estimated $2.35M and leaving 2,050,843 shares worth $14.8M. The position accounts for 0.02% of the portfolio, ranked #989.

Point72 Asset Management first reported a position in SLDB in Q2 2024 and has held it in 7 quarters since. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Point72 Asset Management held 2,050,843 shares of Solid Biosciences worth $14.8M as of Q1 2026.
  • Point72 Asset Management sold 365,265 Solid Biosciences shares in Q1 2026, an estimated $2.35M.
  • Solid Biosciences made up 0.02% of Point72 Asset Management's portfolio in Q1 2026, its #989 holding.
  • Point72 Asset Management first reported a position in Solid Biosciences in Q2 2024 and has held it in 7 quarters since.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.